4//SEC Filing
HOUGEN ELIZABETH L 4
Accession 0000874015-25-000238
CIK 0000874015other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:55 PM ET
Size
8.9 KB
Accession
0000874015-25-000238
Insider Transaction Report
Form 4
HOUGEN ELIZABETH L
EVP, Finance & CFO
Transactions
- Sale
Common Stock
2025-09-30$65.26/sh−49,800$3,249,734→ 110,500 total - Exercise/Conversion
Common Stock
2025-09-30$53.77/sh+49,800$2,677,746→ 160,300 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-30−49,800→ 0 totalExercise: $53.77From: 2020-01-02Exp: 2026-01-01→ Common Stock (49,800 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.52 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001074773
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:55 PM ET
- Size
- 8.9 KB